SEOM clinical guideline thyroid cancer (2019)

Thyroid carcinoma is the most frequent endocrine malignancy and accounts for around 3% of global cancer incidence. Different histologies and clinical scenarios make necessary a multidisciplinary approach that includes new diagnostic methods and surgical, radiopharmaceutical and systemic therapies. T...

Full description

Bibliographic Details
Authors: Gallardo, E, Medina, J, Sanchez, JC, Viudez, A, Grande, E, Porras, I, Cajal, TRY, Trigo, J, Iglesias, L, Capdevila, J
Format: article
Status:Published version
Publication Date:2020
Country:España
Institution:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repository:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p1525
Online Access:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1525
Access Level:Open access
Keyword:Thyroid cancer
Multidisciplinary
Systemic therapy
Description
Summary:Thyroid carcinoma is the most frequent endocrine malignancy and accounts for around 3% of global cancer incidence. Different histologies and clinical scenarios make necessary a multidisciplinary approach that includes new diagnostic methods and surgical, radiopharmaceutical and systemic therapies. This guideline updates several aspects of management of thyroid cancer.